Canscora

Canscora: A Comprehensive Reference

1. Identity and Botanical Classification

1.1 Genus Overview

Canscora is a genus of 9 to 30 species of plants in the family Gentianaceae, native to Africa, Asia, and Australia, several species of which are used medicinally. Within the classification hierarchy, Canscora sits in the kingdom Plantae, phylum Tracheophyta, class Magnoliopsida, order Gentianales, and family Gentianaceae. The genus was formally described by the French botanist Lamarck in 1785. The taxonomy of the genus Canscora (subtribe Canscorinae, family Gentianaceae) has long been considered problematic, mainly due to pronounced interspecific and intraspecific morphological variation.

1.2 Principal Medicinal Species

Two species account for the overwhelming majority of ethnobotanical and pharmacological attention: Canscora decussata (Roxb.) Roem. & Schult. and Canscora diffusa (Vahl) R.Br. ex Roem. & Schult. A range of additional species — including C. alata, C. andrographioides, C. perfoliata, C. roxburghii, and others — have been documented in botanical floristic surveys.

1.3 Canscora decussata — The Primary Medicinal Species

Canscora decussata (Roxb.) Roem. & Schult. — also written as C. decussata Schult. in some earlier literature — is by far the most extensively studied species in a pharmacological context. It is popularly known as "shankhpushpi" and is a threatened medicinal plant. In southern parts of India, C. decussata is popularly known as "Shankhpushpi" and is found above an altitude of 1300 m; it is also grown in Sri Lanka and Myanmar.

The plant carries multiple vernacular names across South Asian languages. In Sanskrit it is known as Sankhapuspi or Sankhini; in Hindi as Sankhabati, Shankhaphuli, Shankhapuspi, or Samkhaphuli; in Bengali as Dankuni; in Malayalam as Kancankora or Samkhapuspi; in Telugu as Kancakura; and in Kannada as Sankinisoppy.

1.4 Canscora diffusa — The Broadly Distributed Species

Canscora diffusa (Vahl) R.Br. ex Roemer & Schultes has a very large area of distribution: it is widespread in tropical Africa, tropical Asia, tropical Australia, and New Caledonia. In tropical Asia, it has been reported for Nepal, India, Sri Lanka, Vietnam, Laos, Thailand, Java (western part, scarce), and the Philippines (widespread), but probably also occurs elsewhere. The native range spans tropical Africa to the SW Pacific, and it is an annual growing primarily in the seasonally dry tropical biome. Morphologically, it is an annual erect herb up to 35–70 cm tall, much branched, with a slender, four-angled, glabrous stem. Diffutidin and diffutin are flavans, a type of flavonoid, found in C. diffusa.

1.5 Botanical Description of C. decussata

Canscora decussata Schult. are small erect herbs, the phytoconstituents of which include the phenolic compounds scopoletin and mangiferin, alkaloids, xanthones, sterols, flavonoids, and triterpenoids. The species name "decussata" refers to the cross-arranged (decussate) pattern of its opposite leaves, a key morphological identifier.

1.6 Conservation Status

Due to the rapid destruction of natural habitats, in vitro methods are being explored that might save endangered species; winged-stem Canscora is classified as an endangered medicinal herb used in traditional medicine for brain disorders. The pressures of wild harvesting for commercial Ayurvedic formulations have intensified these conservation concerns.

1.7 Common Preparations and Dosage Forms

The entire plant, as well as its fresh juice, is used in medicine. Commercially, C. decussata-based commercial formulations for memory development include preparations such as "Stress guard pills" and "Shankhpushpi syrup," and the plant is used both as a solo medicine and in combination with other treatments; it is found as an active ingredient in majority of formulas available on the marketplace as tablets, syrups, and capsules, such as Dimagheen (Dawakhana Tibiya College), Unjha Shankhpushpi Syrup, Narnarayan Pharmacy Shankhavali Churna, BR-16A (Himalaya Drug Co. Ltd), and Shankapuspi Hills capsule (Herbal Hills).

---

2. Traditional and Historical Use

2.1 Ayurveda: India's Classical Medical System

In southern India, Ayurvedic practitioners traditionally employ the whole herb of Canscora decussata Schult. (Gentianaceae) as a traditional Ayurvedic medicine, Shankhpushpi, for its memory potentiating, anxiolytic, and tranquilizing properties. The whole plant is used in the well-known Indian traditional medicinal system called Ayurveda to prepare various drug formulations.

Shankhpushpi is a drug of the Ayurvedic "Medhya Rasayana" category, which is used to boost memory and intellect. The "Medhya Rasayana" concept in Ayurveda refers to a class of preparations specifically intended to enhance mental faculties, and C. decussata occupies a position within this category alongside several other herbs.

The entire plant, as well as its fresh juice, is used in traditional medicine for the treatment of insanity, epilepsy, and nervous debility. They were also used in the Ayurvedic system as brain tonics.

2.2 The "Shankhpushpi" Controversy

A critical point of historical and practical significance is that the name "Shankhpushpi" is applied to multiple botanically distinct plants in different regions of India. There is plurality regarding the botanical identity of Shankhapushpi, with named botanical sources including Convolvulus pluricaulis, Evolvulus alsinoides, Clitorea ternatea, and Canscora decussata, all of which are indigenous to the Indian subcontinent. This means that traditional references to "Shankhpushpi" in classical Ayurvedic texts may not always refer specifically to C. decussata, complicating the interpretation of historical ethnobotanical records and making direct comparisons of traditional use claims difficult.

2.3 Traditional Uses in Southern India and Sri Lanka

Canscora decussata, popularly known as shankhpushpi, is a herb used as a laxative and a tonic, and several medicinal properties have been attributed to it in traditional medicine in India. The traditional therapeutic profile spans neurological, gastrointestinal, and general tonic applications. Shankhpushpi, as an important drug of the indigenous system of medicine, is known as a brain tonic, alterative, and laxative.

2.4 Use in the Philippines (C. diffusa)

In the Philippines, a decoction of the whole plant of C. diffusa is used as a tonic and antigastralgic, and is used as a substitute for tea. C. decussata from tropical Africa, Madagascar, and mainland tropical Asia is used in India as a laxative, alterative, and nerve tonic; C. diffusa is sometimes used there as a substitute.

2.5 Postmenopausal and Women's Health Applications

Herbal formulations containing C. decussata (such as "Menotab") have reportedly restored a feeling of well-being in postmenopausal women, relieved irritability, promoted confidence, and kept patients energetic, while also demonstrating mild antidepressant activity and prevention of hot flushes, insomnia, and fatigue.

---

3. Key Phytoconstituents and Active Compounds

3.1 Xanthones

Xanthones represent the most extensively characterized class of secondary metabolites in C. decussata. Chaudhuri and Ghosal reported, in 1971, that the roots of C. decussata have been shown to contain 16 xanthones (I–XVI), 6 of which have not been previously reported. Their identity was established with the use of various chemical and spectral methods, including comparison with authentic synthetic samples; identified structures include mangiferin (1,3,6,7-tetrahydroxy xanthone-C-glucoside), as well as 1,5-dihydroxy-3-methoxy, 1-hydroxy-3,5-dimethoxy, 1,3,5-trihydroxy-6-methoxy, and numerous other hydroxymethoxy xanthone variants.

C. decussata contains several xanthones, triterpenoids, flavonoids, coumarin derivatives, and loliolides; mangiferin (a xanthone glycoside) and scopoletin (a phenolic coumarin) are the two major phytoconstituents confirmed by high-performance thin-layer chromatography (HPTLC) and are important for CNS activity.

Aerial parts of Canscora decussata have been shown to contain 1-methoxy-3,5-dihydroxyxanthone and its 3-O-rutinosyl derivative; the identity of these compounds was established by chemical transformation and spectral evidence, and this is the first demonstration of the occurrence of these two compounds in nature.

3.2 Mangiferin — The Major Xanthone

Mangiferin is a polyphenolic xanthone, whereas scopoletin is a coumarin; they are responsible for the antioxidant and memory-enhancing activities in Canscora decussata (Roxb.) Roem. & Schult., Gentianaceae. The most widely occurring xanthone, mangiferin, in this plant has also proved its potential for CNS stimulation. Scopoletin, a coumarin, and mangiferin, a polyphenolic xanthone, are two important bioactive components responsible for most of the therapeutic bioactivity; the ability of C. decussata to improve memory and cognition was specifically associated with the presence of mangiferin.

Owing to the xanthone chemical structure, mangiferin has a redox-active aromatic system and antioxidant properties; it exerts varied and impressive metabolic effects in animals, improving metabolic disorders.

3.3 Scopoletin (Phenolic Coumarin)

Scopoletin (6-methoxy-7-hydroxycoumarin) is a well-characterized phenolic coumarin co-occurring with mangiferin in C. decussata. Sethiya et al. (2015) proposed a method to estimate mangiferin and scopoletin in the hydroalcoholic extract of C. decussata, used as phytomarkers in traditional Ayurvedic medicine. Both mangiferin and scopoletin are now routinely used as analytical markers for quality control and standardization of C. decussata-based preparations.

3.4 Additional Phytoconstituents

This plant is reported to contain several types of phenolics, xanthones, bitter substances, oleoresin, triterpenoids, loliolide, sterols, and flavonoids. Specifically, Canscora decussata (Shankhpushpi) belongs to the Gentianaceae family and has therapeutically critical secondary metabolites, including xanthones, triterpenoids, loliolide, sterols, and flavonoids. GC-MS analyses of methanol extracts have further identified compounds including 2,4-bis(1-phenylethyl)amyrin, methylcommate D, and 4-acetyl-3-hydroxy-2,6-dimethoxytoluene.

---

4. Mechanisms of Action

4.1 Acetylcholinesterase Inhibition

The cognition-boosting study investigated the effect of C. decussata for its effects on learning and memory in rodents; the extract was further studied for its in vitro acetylcholinesterase (AChE) inhibitory potential, which can correlate with its cognition-boosting effect. Astonishingly, C. decussata has the highest AChE inhibitory activity of any of the Shankhpushpi herbs. By inhibiting AChE, the enzyme responsible for breaking down the neurotransmitter acetylcholine, extracts of C. decussata may sustain cholinergic transmission, a mechanism shared by several approved pharmaceutical treatments for cognitive impairment.

4.2 Neuroprotective Signaling Effects

C. decussata has been shown to be an antioxidant with a direct effect on signaling mechanisms to improve neural communication, improve neuroprotective adaptation, reduce stress signaling, modulate extracellular signaling for kinase activity, increase insulin-like growth factor I (IGF-I), and regulate MAPK signaling, all of which significantly contribute to cognitive improvement.

4.3 CNS Depressant vs. Stimulant Activity

Pharmacological studies of mangiferin, the major and most polar xanthone of Canscora decussata, showed definite signs of CNS stimulation, as well as hydrochloretic effect, cardiostimulant effect, and potentiation of sub-analgesic doses of morphine; the less polar xanthones, from the petroleum extract of the roots, elicited only a weak CNS depressant activity. Selected pharmacological screening of the water-soluble xanthones indicated that this fraction contained the active principle(s) of the plant. This dual character — CNS stimulant activity from the polar xanthone fraction and depressant activity from the less polar fraction — may explain the plant's traditional reputation as both a nervine tonic and a tranquilizing agent.

4.4 Anti-inflammatory Mechanisms

The ethanolic extract of the herb lowers blood pressure in albino rats and also shows stimulant action on the smooth muscle of intestine, uterus, and bronchus. A regulated expression of cell adhesion molecules, such as ICAM-1, VCAM-1, and E-selectin, on endothelial cells is essentially required for immune surveillance; cell adhesion molecules regulate the extravasation and migration of the body's effector cells to the site of immune activation; failure of their expression leads to various pathological diseases; results demonstrate that an aqueous extract prepared from Canscora decussata promotes the adhesion of peripheral neutrophils to human umbilical vein endothelial cells.

4.5 Antitubercular Activity

The purified xanthones from Canscora decussata have shown inhibitory activity against Mycobacterium tuberculosis H37 Rv (Ghosal et al., 1978). This work, published in the Journal of Pharmaceutical Sciences in 1975, was among the earliest pharmacological studies to document a specific mechanism for a constituent of C. decussata.

---

5. Scientific Evidence by Area of Use

5.1 Cognition and Memory Enhancement

Type of Evidence: Preclinical (animal and in vitro).

In southern India, Ayurvedic practitioners traditionally employ the whole herb of C. decussata as Shankhpushpi for its memory potentiating, anxiolytic, and tranquilizing properties; a key study investigated its effects on learning and memory in rodents and further assessed its in vitro AChE inhibitory potential; ethanol extract was analyzed by HPTLC and HPLC. The findings support the use of C. decussata as Shankhpushpi (a nervine tonic in traditional Ayurvedic medicine); the pharmacological actions of C. decussata justify its therapeutic uses in mental disorders such as melancholia; and these findings validate the traditional claims of C. decussata as a memory-improving herb.

The memory-enhancing activity has been well documented due to the presence of the compound mangiferin in C. decussata.

Limitations: All published cognition studies reviewed are in rodent models or in vitro. No peer-reviewed randomized controlled trial (RCT) in human populations specifically evaluating C. decussata for memory enhancement has been identified. Clinical trials of marketed formulations showed very encouraging results, however the PMC review note referencing this does not provide details of design, population size, or outcomes, and the methodological quality of these trials cannot be assessed from the available published literature.

5.2 Anticonvulsant Activity

Type of Evidence: Preclinical (animal).

An ethanolic extract from the aerial parts of this plant showed muscle relaxant activity in an animal model; the powdered plant as well as the alcoholic extracts attenuated chronic (but not acute) convulsive activity in rodents, but total xanthones as well as mangiferin (the major and most polar xanthone of Canscora decussata) have no acute anticonvulsant action.

Animals in one study were tested for toxicity before clinical trial; Group A with acute-type convulsions showed no effect, whereas Group B with chronic-type convulsions showed better effect. Dikshit et al. reported that crude dried powder and its alcoholic extract, with reference to phenytoin sodium as positive control, were found to provide 100% protection against supramaximal electroshock (a convulsion induced with a current of 150 mA for 0.2 s); the reported ED50 value was found to be 62 mg/100 g for crude powder, 7.6 mg/100 g for alcoholic extract, and 1.4 mg/100 g for phenytoin sodium, respectively.

Limitations: Evidence is entirely preclinical. The distinction between chronic and acute convulsive models suggests that clinical translation is not straightforward. No human RCTs have been identified.

5.3 Antidiabetic and Hypoglycemic Activity

Type of Evidence: Preclinical (animal — alloxan-induced diabetic rabbits).

In one study, the hypoglycemic effects of crude powdered C. decussata and its methanolic extract (ME) in alloxan-diabetic rabbits were evaluated; the hypoglycemic effect was measured by blood glucose, insulin level, HbA1c, and histopathology of the pancreas; glucose-lowering effect of the ME was studied in diabetic rabbits along with effects on body weight, food intake, fluid intake, and oral glucose tolerance test (OGTT); results showed that 0.5, 1, and 2 g/kg of the powder significantly decreased blood glucose levels in normal rabbits and diabetic rabbits at all intervals checked. Synergistic hypoglycemic effect of 600 mg/kg of ME with different doses of insulin (2 and 3 units/kg, subcutaneous) further reduced blood glucose levels of treated alloxan-diabetic rabbits; the oral glucose tolerance test revealed lowered area under the curve values in ME-treated rabbits.

Limitations: All antidiabetic studies are in animal models. The alloxan-induced diabetic rabbit model does not fully replicate human type 1 or type 2 diabetes pathophysiology. No human clinical trials on glycemic control with C. decussata have been identified in the peer-reviewed literature.

5.4 Anti-inflammatory Activity

Type of Evidence: In vitro and animal (carrageenan paw-edema model).

A study published in the Journal of Ethnopharmacology (ScienceDirect) investigated the ability of C. decussata extract to inhibit LPS-induced expression of ICAM-1 and E-selectin on endothelial cells and carrageenan-induced paw edema in rats. No prior studies had, however, been undertaken to explore the anti-inflammatory activity of this plant, making this work an early investigation; the study examined the ability of the extract to influence expression of ICAM-1 and E-selectin on endothelial cells and inflammatory response in rat paw edema models.

Limitations: Evidence is in vitro and in rodent models only. No human anti-inflammatory trials have been published.

5.5 Antitubercular Activity

Type of Evidence: In vitro (microbiological).

Antitubercular activity of xanthones of Canscora decussata Schult. was reported by Ghosal and Chaudhuri in a 1975 paper published in the Journal of Pharmaceutical Sciences (Vol. 64, No. 5). The purified xanthone fraction showed in vitro inhibitory activity against Mycobacterium tuberculosis H37 Rv. This is preliminary, in vitro evidence only; no subsequent clinical studies on this application have been identified.

5.6 Antioxidant Activity

Type of Evidence: In vitro.

C. decussata extracts have been analyzed using GC-MS analysis to elucidate their pharmaceutical efficacy; findings revealed that methanol extract derived from wild plants demonstrated superior antioxidant activity and contained richer phytochemical constituents compared to in vitro-propagated plants. Antioxidant activity has been consistently demonstrated across multiple studies using DPPH free radical scavenging, hydrogen peroxide, and ferric chloride reduction assays. The antioxidant capacity is largely attributed to the high phenolic and flavonoid content of the plant.

Limitations: All antioxidant data are in vitro. In vitro antioxidant assay results do not directly translate to antioxidant effects in vivo in humans.

5.7 Anxiolytic Activity

Type of Evidence: Preclinical (animal).

Sethiya, Nahata, and Dixit published a study titled "Anxiolytic Activity of Canscora decussata in Albino Rats" in the Journal of Complementary and Integrative Medicine (2010, Vol. 7, Issue 1, Article 19). This study provided preclinical support for the traditional use of C. decussata as a tranquilizing and anxiolytic herb. However, no human anxiolytic clinical trial specifically for C. decussata has been identified in the peer-reviewed literature.

5.8 Cardiostimulant Activity

Type of Evidence: Preclinical (animal/in vitro).

Mangiferin showed definite signs of CNS stimulation; hydrochloretic effect, cardiostimulant effect, and potentiation of sub-analgesic doses of morphine were also demonstrated. A sub-chronic administration study of C. decussata leaf extract on liver and heart of Wistar rats concluded that Canscora decussata is relatively safe for use and may be of benefit in cardiovascular and hepatic conditions.

5.9 Immunomodulatory Activity

Type of Evidence: In vitro.

A regulated expression of cell adhesion molecules such as ICAM-1, VCAM-1, and E-selectin on endothelial cells is essentially required for immune surveillance; cell adhesion molecules regulate the extravasation and migration of effector cells to sites of immune activation; failure of their expression leads to various pathological diseases; an aqueous extract prepared from Canscora decussata (CdAqE) was shown to promote the adhesion of peripheral neutrophils to human umbilical vein endothelial cells.

5.10 Spermicidal Activity

Type of Evidence: Preclinical (animal).

The plant has demonstrated spermicidal activity in rats. This plant proved its potential in CNS stimulation, hypertension, convulsion, tuberculosis, immunomodulation, inflammation, hepatoprotection, spermatogenesis, and postmenopausal osteoporosis. These findings are from preclinical animal studies, and the implications for human reproductive health have not been established in clinical trials.

5.11 Hepatoprotective Activity

Type of Evidence: Preclinical (animal) and in vitro.

Canscora decussata is traditionally believed to relieve cardiovascular and hepatic disorders; a study evaluated the biochemical and histological effect of sub-chronic administration of ethanol leaf extract of Canscora decussata on the liver and heart of Wistar rats; twenty-four male adult rats were used, with Group 1 receiving distilled water (10 ml/kg) and Groups 2, 3, and 4 receiving 100, 200, and 400 mg/kg of C. decussata, respectively. There was significant decrease in serum albumin at 200 and 400 mg/kg dose, while there was no significant change in ALT and ALP compared to the control group; there was significant increase in cholesterol level at 200 mg/kg dose compared to the control.

5.12 Evidence Regarding Postmenopausal Symptoms

Type of Evidence: Clinical (open-label trial, polyherbal formulation).

The herbs in the formulation (Menotab) restored a feeling of well-being in postmenopausal women; they relieve irritability, promote confidence, and keep patients energetic; Menotab has a mild antidepressant activity and prevents hot flushes, insomnia, and fatigue; it has a high content of natural calcium, which helps to control postmenopausal osteoporosis; the study has shown that Menotab is an ideal medication for relief of postmenopausal symptoms as a short-term therapy; it is also reported as safe and effective, with no adverse side effects. It should be noted that Menotab is a multi-ingredient polyherbal formulation; attributing observed effects specifically to C. decussata rather than to the combination is not possible from this study design.

---

6. Body Systems and Health Areas

Based on the published preclinical and limited clinical evidence reviewed, Canscora decussata has been investigated across the following body systems and health areas:

• Central Nervous System: Memory, cognition, learning, anxiety, convulsions, nervous debility, mental health disorders including melancholia and insanity.
• Cardiovascular System: Cardiostimulant effects, blood pressure modulation, cholesterol regulation.
• Immune System: Immunomodulation, neutrophil adhesion, anti-inflammatory responses.
• Metabolic/Endocrine: Glycemic regulation, antidiabetic potential, antihyperlipidemic effects.
• Hepatic System: Hepatoprotective properties.
• Reproductive System: Spermatogenesis, spermicidal activity, uterine smooth muscle stimulation.
• Musculoskeletal: Postmenopausal osteoporosis (via multi-ingredient formulations).
• Antimicrobial: Antitubercular activity against M. tuberculosis H37 Rv; antimicrobial activity of leaf and root fractions.

Its therapeutic and pharmacognostic potential includes acetylcholinesterase inhibition, anti-Parkinson activity, anti-convulsions, anti-diabetic, anti-inflammation, anti-depressant, anti-hypertension, anti-mycobacterium, anti-viral, CNS stimulation, hepatoprotective, immunomodulation, regulating postmenopausal osteoporosis, and spermatogenesis.

Extracts and bioactive compounds from the plant have been found to possess antimicrobial, anthelmintic, antitermite, nephroprotective, hepatoprotective, central nervous system protective, antitumour, antidiabetic, anticataract, antioxidant, haematopoietic, diuretic, antinociceptive, anti-inflammatory, and antipyretic activities.

---

7. Dosage Forms and Doses Reported in Studies

No standardized pharmacopeial monograph dosage exists for C. decussata in major Western pharmacopeias. The doses described below are drawn strictly from specific study publications and should be understood as doses used in those preclinical experimental contexts:

• Crude powder at 0.5, 1, and 2 g/kg of body weight significantly decreased blood glucose levels in normal and alloxan-diabetic rabbits at the intervals checked.
• A synergistic hypoglycemic effect was observed at 600 mg/kg of methanolic extract combined with different doses of insulin (2 and 3 units/kg, subcutaneous) in treated alloxan-diabetic rabbits.
• In the sub-chronic hepatic and cardiac safety study, twenty-four male adult Wistar rats were used; Group 1 received distilled water (10 ml/kg), while Groups 2, 3, and 4 received 100, 200, and 400 mg/kg of Canscora decussata ethanol leaf extract, respectively.
• The ED50 value for anticonvulsant activity was reported to be 62 mg/100 g for crude powder, 7.6 mg/100 g for alcoholic extract, and 1.4 mg/100 g for phenytoin sodium (positive control), respectively, using a supramaximal electroshock model in rodents.

Commercially, Canscora decussata-based formulations for memory development are marketed as tablets, syrups, and capsules, but specific dosage recommendations from the manufacturers are not established in the published peer-reviewed literature reviewed here.

---

8. Safety Considerations

8.1 Preclinical Toxicity Data

Canscora decussata was found to be relatively safe for use in a sub-chronic animal study, and may be of benefit in cardiovascular and hepatic conditions.

However, at 200 and 400 mg/kg doses in Wistar rats, there was a significant decrease in serum albumin, while there was no significant change in ALT and ALP compared to the control group; a significant increase in cholesterol level was observed at the 200 mg/kg dose. There was a significant increase in serum HDL at the 400 mg/kg dose, while LDL and triglyceride values remained unchanged; slight lymphocyte hyperplasia with normal heart and liver histological architecture was observed at all doses. These findings suggest that while the plant appears generally tolerated at these doses in the animal model, the observed changes in albumin warrant attention in longer-term or higher-dose studies.

8.2 Cytotoxicity

Both callus and elicited callus extracts of C. decussata were found to be much less toxic (IC50 >200 μg/mL) than wild plants in in vitro cytotoxicity testing.

8.3 Spermicidal and Uterotonic Effects

The ethanolic extract of the herb lowers blood pressure in albino rats and shows stimulant action on the smooth muscle of intestine, uterus, and bronchus; it also has spermicidal activity in rats. The stimulant effect on uterine smooth muscle is a factually documented preclinical finding with potential relevance to reproductive safety, particularly in pregnant individuals, though no human data are available.

8.4 Botanical Identity Concerns and Quality Control

There is plurality regarding the botanical identity of Shankhapushpi, with multiple botanically distinct plants — including Convolvulus pluricaulis, Evolvulus alsinoides, Clitorea ternatea, and Canscora decussata — all marketed under this single name. This creates a significant risk of product misidentification in commercial supply chains. Products labeled as "Shankhpushpi" may or may not contain C. decussata specifically.

8.5 Conservation and Supply Concerns

Due to the rapid destruction of natural habitats, in vitro propagation methods are being investigated; winged-stem Canscora is classified as an endangered medicinal herb. Heavy reliance on wild-harvested plant material raises concerns about both supply sustainability and chemical consistency of commercial preparations, as wild-harvested material has been shown to have higher phytochemical content than in vitro material.

8.6 Absence of Human Safety Trials

No formal Phase I dose-escalation safety study specifically for C. decussata in human populations has been identified in the peer-reviewed literature reviewed for this article. All safety inferences for humans are extrapolated from animal and in vitro studies. The preclinical body of evidence is consistent with relative short-term tolerability at the doses tested, but long-term human safety data are absent.

8.7 Interactions

The documented in vitro AChE inhibitory activity of C. decussata raises the theoretical possibility of additive or potentiating effects when co-administered with pharmaceutical acetylcholinesterase inhibitors (such as donepezil or rivastigmine). This interaction has not been evaluated in human pharmacokinetic or pharmacodynamic studies. The cardiostimulant activity documented in pharmacological studies similarly warrants consideration in the context of cardiovascular medications, though no human data are available.

---

References

• Sethiya NK, Patel MB, Mishra SH. Phytopharmacologic aspects of Canscora decussata Roem and Schult. Pharmacognosy Reviews. 2010 Jan;4(7):49–57. PMC3249902.
• Sethiya NK, Patel MB, Mishra SH. Phytopharmacologic aspects of Canscora decussata Roem and Schult. PubMed PMID: 22228941.
• Cognition boosting effect of Canscora decussata (a South Indian Shankhpushpi). ScienceDirect (Journal of Ayurveda and Integrative Medicine, 2012).
• Sethiya NK et al. Rapid validated HPTLC method for simultaneous estimation of mangiferin and scopoletin in Canscora decussata extract. ScienceDirect (Revista Brasileira de Farmacognosia, 2015).
• Bhattacharya SK et al. Canscora decussata (Gentianaceae) Xanthones III: Pharmacological Studies. ScienceDirect (Journal of Pharmaceutical Sciences).
• Kousalya L et al. Ameliorated antioxidant and phytochemical profiling of Canscora decussata – An Ayurvedic medicinal plant. ScienceDirect (Journal of Ethnopharmacology, 2023).
• Canscora decussata inhibits LPS-induced expression of ICAM-1 and E-selectin on endothelial cells and carrageenan-induced paw-edema in rats. ScienceDirect (Journal of Ethnopharmacology, 2004).
• Effect of growth regulators on rapid micropropagation and antioxidant activity of Canscora decussata — a threatened medicinal plant. ScienceDirect (Arabian Journal of Chemistry, 2016).
• Chitosan (CTS) induced secondary metabolite production in Canscora decussata Schult. — An endangered medicinal plant. ScienceDirect (South African Journal of Botany, 2024).
• Hypoglycaemic effects of methanolic extract of Canscora decussata (Schult) whole-plant in normal and alloxan-induced diabetic rabbits. PubMed PMID: 25553693.
• Canscora decussata (Gentianaceae) xanthones. 3. Pharmacological studies. PubMed PMID: 4652665.
• Ghosal S, Chaudhuri RK. Chemical constituents of Gentianaceae XVI: antitubercular activity of xanthones of Canscora decussata Schult. Journal of Pharmaceutical Sciences. 1975;64(5):888–9. PubMed PMID: 807707.
• Canscora decussata promotes adhesion of neutrophils to human umbilical vein endothelial cells. PubMed PMID: 11801386.
• Andrade C et al. Investigation of the possible role of Shankapushpi in the attenuation of ECT induced amnestic deficits. Indian Journal of Psychiatry. 2012;54(2):166–71. PMC3440912.
• Sethiya NK et al. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India. Journal of Advanced Pharmaceutical Technology & Research. 2010;1(4):388–95. PMC3255406.
• GBIF Backbone Taxonomy. Canscora Lam. Global Biodiversity Information Facility.
• Canscora diffusa (Vahl) R.Br. ex Roem. & Schult. Plants of the World Online. Royal Botanic Gardens, Kew.
• Canscora diffusa (PROSEA). Pl@ntUse / PROSEA.
• Arun Prasanth R et al. Identity and taxonomic status of Canscora diffusa var. tetraptera (Gentianaceae). Kew Bulletin. 2021;76(4):851–855.
• Taxonomic reassessment of Canscora bidoupensis (Gentianaceae) and its systematic position. Phytotaxa, 2026.
• Adegbuyi AT et al. Biochemical and Histological Evaluation of Sub-Chronic Administration of Canscora decussate Leaf Extract on Liver and Heart of Wistar Rats. Tropical Journal of Phytochemistry and Pharmaceutical Sciences.
• Sethiya NK, Patel MB, Mishra SH. Phytopharmacologic Aspects of Canscora decussata Roem and Schult. Pharmacognosy Reviews. 2010;4(7):49–57.
• Canscora. Wikipedia (used for species list cross-reference only).